Cargando…

A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation

Nanobodies (Nbs) are soluble, versatile, single-domain binding modules derived from the VHH variable domain of heavy-chain antibodies naturally occurring in camelids. Nbs hold huge promise as novel therapeutic biologics. Membrane proteins are among the most interesting targets for therapeutic Nbs be...

Descripción completa

Detalles Bibliográficos
Autores principales: Eden, Thomas, Menzel, Stephan, Wesolowski, Janusz, Bergmann, Philine, Nissen, Marion, Dubberke, Gudrun, Seyfried, Fabienne, Albrecht, Birte, Haag, Friedrich, Koch-Nolte, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787055/
https://www.ncbi.nlm.nih.gov/pubmed/29410663
http://dx.doi.org/10.3389/fimmu.2017.01989
_version_ 1783295852847038464
author Eden, Thomas
Menzel, Stephan
Wesolowski, Janusz
Bergmann, Philine
Nissen, Marion
Dubberke, Gudrun
Seyfried, Fabienne
Albrecht, Birte
Haag, Friedrich
Koch-Nolte, Friedrich
author_facet Eden, Thomas
Menzel, Stephan
Wesolowski, Janusz
Bergmann, Philine
Nissen, Marion
Dubberke, Gudrun
Seyfried, Fabienne
Albrecht, Birte
Haag, Friedrich
Koch-Nolte, Friedrich
author_sort Eden, Thomas
collection PubMed
description Nanobodies (Nbs) are soluble, versatile, single-domain binding modules derived from the VHH variable domain of heavy-chain antibodies naturally occurring in camelids. Nbs hold huge promise as novel therapeutic biologics. Membrane proteins are among the most interesting targets for therapeutic Nbs because they are accessible to systemically injected biologics. In order to be effective, therapeutic Nbs must recognize their target membrane protein in native conformation. However, raising Nbs against membrane proteins in native conformation can pose a formidable challenge since membrane proteins typically contain one or more hydrophobic transmembrane regions and, therefore, are difficult to purify in native conformation. Here, we describe a highly efficient genetic immunization strategy that circumvents these difficulties by driving expression of the target membrane protein in native conformation by cells of the immunized camelid. The strategy encompasses ballistic transfection of skin cells with cDNA expression plasmids encoding one or more orthologs of the membrane protein of interest and, optionally, other costimulatory proteins. The plasmid is coated onto 1 µm gold particles that are then injected into the shaved and depilated skin of the camelid. A gene gun delivers a helium pulse that accelerates the DNA-coated particles to a velocity sufficient to penetrate through multiple layers of cells in the skin. This results in the exposure of the extracellular domains of the membrane protein on the cell surface of transfected cells. Repeated immunization drives somatic hypermutation and affinity maturation of target-specific heavy-chain antibodies. The VHH/Nb coding region is PCR-amplified from B cells obtained from peripheral blood or a lymph node biopsy. Specific Nbs are selected by phage display or by screening of Nb-based heavy-chain antibodies expressed as secretory proteins in transfected HEK cells. Using this strategy, we have successfully generated agonistic and antagonistic Nbs against several cell surface ecto-enzymes and ligand-gated ion channels.
format Online
Article
Text
id pubmed-5787055
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57870552018-02-06 A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation Eden, Thomas Menzel, Stephan Wesolowski, Janusz Bergmann, Philine Nissen, Marion Dubberke, Gudrun Seyfried, Fabienne Albrecht, Birte Haag, Friedrich Koch-Nolte, Friedrich Front Immunol Immunology Nanobodies (Nbs) are soluble, versatile, single-domain binding modules derived from the VHH variable domain of heavy-chain antibodies naturally occurring in camelids. Nbs hold huge promise as novel therapeutic biologics. Membrane proteins are among the most interesting targets for therapeutic Nbs because they are accessible to systemically injected biologics. In order to be effective, therapeutic Nbs must recognize their target membrane protein in native conformation. However, raising Nbs against membrane proteins in native conformation can pose a formidable challenge since membrane proteins typically contain one or more hydrophobic transmembrane regions and, therefore, are difficult to purify in native conformation. Here, we describe a highly efficient genetic immunization strategy that circumvents these difficulties by driving expression of the target membrane protein in native conformation by cells of the immunized camelid. The strategy encompasses ballistic transfection of skin cells with cDNA expression plasmids encoding one or more orthologs of the membrane protein of interest and, optionally, other costimulatory proteins. The plasmid is coated onto 1 µm gold particles that are then injected into the shaved and depilated skin of the camelid. A gene gun delivers a helium pulse that accelerates the DNA-coated particles to a velocity sufficient to penetrate through multiple layers of cells in the skin. This results in the exposure of the extracellular domains of the membrane protein on the cell surface of transfected cells. Repeated immunization drives somatic hypermutation and affinity maturation of target-specific heavy-chain antibodies. The VHH/Nb coding region is PCR-amplified from B cells obtained from peripheral blood or a lymph node biopsy. Specific Nbs are selected by phage display or by screening of Nb-based heavy-chain antibodies expressed as secretory proteins in transfected HEK cells. Using this strategy, we have successfully generated agonistic and antagonistic Nbs against several cell surface ecto-enzymes and ligand-gated ion channels. Frontiers Media S.A. 2018-01-23 /pmc/articles/PMC5787055/ /pubmed/29410663 http://dx.doi.org/10.3389/fimmu.2017.01989 Text en Copyright © 2018 Eden, Menzel, Wesolowski, Bergmann, Nissen, Dubberke, Seyfried, Albrecht, Haag and Koch-Nolte. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Eden, Thomas
Menzel, Stephan
Wesolowski, Janusz
Bergmann, Philine
Nissen, Marion
Dubberke, Gudrun
Seyfried, Fabienne
Albrecht, Birte
Haag, Friedrich
Koch-Nolte, Friedrich
A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
title A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
title_full A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
title_fullStr A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
title_full_unstemmed A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
title_short A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
title_sort cdna immunization strategy to generate nanobodies against membrane proteins in native conformation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787055/
https://www.ncbi.nlm.nih.gov/pubmed/29410663
http://dx.doi.org/10.3389/fimmu.2017.01989
work_keys_str_mv AT edenthomas acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT menzelstephan acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT wesolowskijanusz acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT bergmannphiline acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT nissenmarion acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT dubberkegudrun acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT seyfriedfabienne acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT albrechtbirte acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT haagfriedrich acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT kochnoltefriedrich acdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT edenthomas cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT menzelstephan cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT wesolowskijanusz cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT bergmannphiline cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT nissenmarion cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT dubberkegudrun cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT seyfriedfabienne cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT albrechtbirte cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT haagfriedrich cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation
AT kochnoltefriedrich cdnaimmunizationstrategytogeneratenanobodiesagainstmembraneproteinsinnativeconformation